Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Bingen

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Infection and Immunity|September 14, 2002
A uropathogenicity island contributes to the pathogenicity of Escherichia coli strains that cause neonatal meningitisVéronique Houdouin, Stéphane Bonacorsi, Naima Brahimi, et al.
The Pediatric Infectious Disease Journal|November 23, 2011
Predictive score to discriminate Kingella kingae from Staphylococcus aureus arthritis in FranceRomain Basmaci, Brice Ilharreborde, Mathie Lorrot, et al.
Journal of Medical Microbiology|March 3, 2012
Use of a new screening medium to detect carbapenem-non-susceptible members of the EnterobacteriaceaeCamille d'Humières, André Birgy, Catherine Doit, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Relapsing erythematous desquamating disorder in a child, with the same toxin-producing Staphylococcus aureus strainJosette Raymond, Edouard Bingen, Florence Moulin, et al.
The Pediatric Infectious Disease Journal|December 18, 2012
Combined relay therapy with oral cefixime and clavulanate for febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coliFouad Madhi, Sandra Biscardi, Edouard Bingen, et al.
The Pediatric Infectious Disease Journal|February 15, 2012
Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis mediaRobert Cohen, Corinne Levy, Edouard Bingen, et al.
Journal of Clinical Microbiology|April 27, 2012
In vitro interaction between cefixime and amoxicillin-clavulanate against extended-spectrum-beta-lactamase-producing Escherichia coli causing urinary tract infectionEdouard Bingen, Philippe Bidet, André Birgy, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2006
Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolatesVéronique Houdouin, Stéphane Bonacorsi, Philippe Bidet, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2013
In vitro interaction between cefepime and amoxicillin-clavulanate against extended-spectrum β-lactamase-producing Escherichia coliEdouard Bingen, Philippe Bidet, Camille D'humières, et al.
Infection and Immunity|January 27, 2004
The siderophore receptor IroN, but not the high-pathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitisValérie Lefranc Nègre, Stéphane Bonacorsi, Soren Schubert, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Infection and Immunity|September 14, 2002
A uropathogenicity island contributes to the pathogenicity of Escherichia coli strains that cause neonatal meningitisVéronique Houdouin, Stéphane Bonacorsi, Naima Brahimi, et al.
The Pediatric Infectious Disease Journal|November 23, 2011
Predictive score to discriminate Kingella kingae from Staphylococcus aureus arthritis in FranceRomain Basmaci, Brice Ilharreborde, Mathie Lorrot, et al.
Journal of Medical Microbiology|March 3, 2012
Use of a new screening medium to detect carbapenem-non-susceptible members of the EnterobacteriaceaeCamille d'Humières, André Birgy, Catherine Doit, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Relapsing erythematous desquamating disorder in a child, with the same toxin-producing Staphylococcus aureus strainJosette Raymond, Edouard Bingen, Florence Moulin, et al.
The Pediatric Infectious Disease Journal|December 18, 2012
Combined relay therapy with oral cefixime and clavulanate for febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coliFouad Madhi, Sandra Biscardi, Edouard Bingen, et al.
The Pediatric Infectious Disease Journal|February 15, 2012
Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis mediaRobert Cohen, Corinne Levy, Edouard Bingen, et al.
Journal of Clinical Microbiology|April 27, 2012
In vitro interaction between cefixime and amoxicillin-clavulanate against extended-spectrum-beta-lactamase-producing Escherichia coli causing urinary tract infectionEdouard Bingen, Philippe Bidet, André Birgy, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2006
Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolatesVéronique Houdouin, Stéphane Bonacorsi, Philippe Bidet, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2013
In vitro interaction between cefepime and amoxicillin-clavulanate against extended-spectrum β-lactamase-producing Escherichia coliEdouard Bingen, Philippe Bidet, Camille D'humières, et al.
Infection and Immunity|January 27, 2004
The siderophore receptor IroN, but not the high-pathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitisValérie Lefranc Nègre, Stéphane Bonacorsi, Soren Schubert, et al.
Pageof 13